Vir Biotechnology (VIR) Equity Ratio (2018 - 2025)
Vir Biotechnology's Equity Ratio history spans 8 years, with the latest figure at 0.76 for Q4 2025.
- On a quarterly basis, Equity Ratio fell 7.21% to 0.76 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.76, a 7.21% decrease, with the full-year FY2025 number at 0.76, down 7.21% from a year prior.
- Equity Ratio hit 0.76 in Q4 2025 for Vir Biotechnology, down from 0.78 in the prior quarter.
- Over the last five years, Equity Ratio for VIR hit a ceiling of 0.86 in Q1 2024 and a floor of 0.57 in Q1 2021.
- Historically, Equity Ratio has averaged 0.77 across 5 years, with a median of 0.79 in 2025.
- Biggest five-year swings in Equity Ratio: decreased 28.09% in 2021 and later grew 20.91% in 2022.
- Tracing VIR's Equity Ratio over 5 years: stood at 0.73 in 2021, then rose by 1.21% to 0.74 in 2022, then rose by 11.74% to 0.83 in 2023, then fell by 0.75% to 0.82 in 2024, then decreased by 7.21% to 0.76 in 2025.
- Business Quant data shows Equity Ratio for VIR at 0.76 in Q4 2025, 0.78 in Q3 2025, and 0.79 in Q2 2025.